{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:03:15Z","timestamp":1783090995836,"version":"3.54.6"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.radonc.2020.07.030","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T11:31:39Z","timestamp":1595417499000},"page":"152-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Prognostic factors for overall survival of stage III non-small cell lung cancer patients on computed tomography: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"151","author":[{"given":"Myra","family":"van Laar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter A.C.","family":"van Amsterdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne S.R.","family":"van Lindert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim A.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9673-0793","authenticated-orcid":false,"given":"Joost J.C.","family":"Verhoeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2020.07.030_b0005","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2020.07.030_b0010","series-title":"World cancer report","author":"Stewart","year":"2003"},{"key":"10.1016\/j.radonc.2020.07.030_b0015","unstructured":"Ervik M, Lam F, Ferlay J, Mery L, Soerjomataram I, Bray F. Cancer today. Cancer Today Lyon, Fr Int Agency Res Cancer 2016. http:\/\/gco.iarc.fr\/today (accessed June 9, 2018)."},{"key":"10.1016\/j.radonc.2020.07.030_b0020","unstructured":"Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. Cancer incidence and mortality worldwide: IACR CancerBase No. 11. GLOBOCAN 2012. http:\/\/globocan.iarc.fr (accessed June 9, 2018)."},{"key":"10.1016\/j.radonc.2020.07.030_b0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.radonc.2020.07.030_b0030","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1590\/S0104-11692013000300019","article-title":"Comparison of the quality of life among persons with lung cancer, before and after the chemotherapy treatment","volume":"21","author":"de","year":"2013","journal-title":"Rev Lat Am Enfermagem"},{"key":"10.1016\/j.radonc.2020.07.030_b0035","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","article-title":"Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer","volume":"28","author":"Aup\u00e9rin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0040","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology non-small cell lung cancer. Version 2. 2019."},{"key":"10.1016\/j.radonc.2020.07.030_b0045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0720-048X(02)00287-5","article-title":"Classification, staging and prognosis of lung cancer","volume":"45","author":"Beadsmoore","year":"2003","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.radonc.2020.07.030_b0050","first-page":"1","article-title":"Non-small-cell lung cancer","volume":"1","author":"Gridelli","year":"2015","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.radonc.2020.07.030_b0055","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ijrobp.2014.07.020","article-title":"Prognostic value and reproducibility of pretreatment CT texture features in stage III non-small cell lung cancer","volume":"90","author":"Fried","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.07.030_b0060","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/RLI.0000000000000174","article-title":"Prognostic value of computed tomography texture features in non-small cell lung cancers treated with definitive concomitant chemoradiotherapy","volume":"50","author":"Ahn","year":"2015","journal-title":"Invest Radiol"},{"key":"10.1016\/j.radonc.2020.07.030_b0065","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00432-018-2640-6","article-title":"Is tumor volume reduction during radiotherapy prognostic relevant in patients with stage III non-small cell lung cancer?","volume":"144","author":"Elsayad","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.lungcan.2004.05.017","article-title":"Pit-fall sign on computed tomography predicts pleural involvement and poor prognosis in non-small cell lung cancer","volume":"46","author":"Li","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2020.07.030_b0075","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s13014-014-0283-6","article-title":"The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy","volume":"9","author":"Koo","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0080","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00259-012-2321-7","article-title":"Prognostic implications of volume-based measurements on FDG PET\/CT in stage III non-small-cell lung cancer after induction chemotherapy","volume":"40","author":"Soussan","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2020.07.030_b0085","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.athoracsur.2016.03.121","article-title":"Cavity wall thickness in solitary cavitary lung adenocarcinomas is a prognostic indicator","volume":"102","author":"Watanabe","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.radonc.2020.07.030_b0090","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2005.07.967","article-title":"Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: Impact of tumor volume","volume":"64","author":"Basaki","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.07.030_b0095","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/JTO.0b013e31821517db","article-title":"Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer","volume":"6","author":"Kozak","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0100","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3109\/03009731003695624","article-title":"Pulmonary atelectasis and survival in advanced non-small cell lung carcinoma","volume":"115","author":"Bulbul","year":"2010","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.radonc.2020.07.030_b0105","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.jtho.2017.08.010","article-title":"Prognostic value of primary tumor volume changes on kV-CBCT during definitive chemoradiotherapy for stage III non\u2013small cell lung cancer","volume":"12","author":"Wald","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0110","doi-asserted-by":"crossref","unstructured":"Wallace BC, Small K, Brodley CE, Lau J, Trikalinos TA. Deploying an interactive machine learning system in an evidence-based practice center: Abstrackr. Proc 2nd ACM SIGHIT Symp Int Heal Informatics \u2013 IHI\u201912 2012:819\u201324. https:\/\/doi.org\/10.1145\/2110363.2110464.","DOI":"10.1145\/2110363.2110464"},{"key":"10.1016\/j.radonc.2020.07.030_b0115","unstructured":"The Cochrane Collaboration. Cochrane handbook for systematic Reviews of interventions. Version 5. 2011."},{"key":"10.1016\/j.radonc.2020.07.030_b0120","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or disagnosis (TRIPOD): Explanantion and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.radonc.2020.07.030_b0125","unstructured":"Scottish Intercollegiate Guidelines Network. SIGN 50: a guideline developer\u2019s handbook. Edinburgh: 2015."},{"key":"10.1016\/j.radonc.2020.07.030_b0130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.6028\/jres.094.020","article-title":"Consensus values, regressions, and weighting factors","volume":"94","author":"Paule","year":"1989","journal-title":"J Res Natl Inst Stand Technol"},{"key":"10.1016\/j.radonc.2020.07.030_b0135","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsisteny in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br Med J"},{"key":"10.1016\/j.radonc.2020.07.030_b0140","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/sim.1752","article-title":"Controlling the risk of spurious findings from meta-regression","volume":"23","author":"Higgins","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.radonc.2020.07.030_b0145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.radonc.2020.07.030_b0150","unstructured":"Harrer M, Cuijpers P, Furukawa T, Ebert D. dmetar: Companion R package for the guide \u201cdoing meta-anaylisis in R\u201d. R package version 0.0.9000 2019."},{"key":"10.1016\/j.radonc.2020.07.030_b0155","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/cas.12771","article-title":"Prognostic value of 18F-fluoroazomycin arabinoside PET\/CT in patients with advanced non-small-cell lung cancer","volume":"106","author":"Saga","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1016\/j.radonc.2020.07.030_b0160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3889\/oamjms.2015.003","article-title":"Prognostic factors and survival in non-small cell lung cancer patients treated with chemoradiotherapy","volume":"3","author":"Crvenkova","year":"2015","journal-title":"Open Access Maced J Med Sci"},{"key":"10.1016\/j.radonc.2020.07.030_b0165","first-page":"1084","article-title":"Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non\u2013small-cell lung cancers","volume":"8","author":"Chaft","year":"2013","journal-title":"JTO Acquis"},{"key":"10.1016\/j.radonc.2020.07.030_b0170","article-title":"Proton beam radiotherapy and concurrent chemotherapy for unresectable stage III non-small cell lung cancer: final results of a phase 2 study. JAMA","volume":"3","author":"Chang","year":"2017","journal-title":"Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0175","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.radonc.2015.05.014","article-title":"Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer","volume":"115","author":"Nguyen","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0180","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ijrobp.2015.02.048","article-title":"A validated prediction model for overall survival from stage III non-small cell lung cancer: toward survival prediction for individual patients","volume":"92","author":"Oberije","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.07.030_b0185","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/sj.bjc.6603075","article-title":"Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-Year follow-up of a phase II study","volume":"94","author":"Betticher","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2020.07.030_b0190","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.acra.2011.12.010","article-title":"Baseline SUVmax at PET-CT in stage IIIA non-small-cell lung cancer patients undergoing surgery after neoadjuvant therapy: Prognostic implication focused on histopathologic subtypes","volume":"19","author":"Lee","year":"2012","journal-title":"Acad Radiol"},{"key":"10.1016\/j.radonc.2020.07.030_b0195","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1200\/JCO.2013.50.5453","article-title":"Prognostic impact of minimal pleural effusion in non-small-cell lung cancer","volume":"32","author":"Ryu","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0200","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2214\/AJR.14.13847","article-title":"Volume-based assessment with 18F-FDG PET\/CT improves outcome prediction for patients with stage IIIA-N2 non-small cell lung cancer","volume":"205","author":"Hyun","year":"2015","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.radonc.2020.07.030_b0205","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1748-717X-7-144","article-title":"FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy","volume":"7","author":"Xiang","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0210","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3892\/mco.2015.509","article-title":"Lower lobe origin is a poor prognostic factor in locally advanced non-small-cell lung cancer patients treated with induction chemoradiotherapy","volume":"3","author":"Shien","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0215","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/1817-1737.56010","article-title":"Prognostic factors and long term results of neo adjuvant therapy followed by surgery in stage IIIA N2 non-small cell lung cancer patients","volume":"4","author":"Li","year":"2009","journal-title":"Ann Thorac Med"},{"key":"10.1016\/j.radonc.2020.07.030_b0220","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/JTO.0b013e3182582912","article-title":"Tumor cavitation in patients with stage III non-small-cell lung cancer undergoing concurrent chemoradiotherapy","volume":"7","author":"Phernambucq","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0225","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/JTO.0b013e3181753b38","article-title":"Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage III non-small cell lung cancer","volume":"3","author":"Naito","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0230","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.lungcan.2011.05.003","article-title":"Lung cancer pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer","volume":"74","author":"Shumway","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2020.07.030_b0235","first-page":"205","article-title":"Concurrent chemoradiotherapy in locally advanced non-small cell lung cancer: a retrospective analysis of the correlation between radiotherapy-related factors and tumor response","volume":"13","author":"Park","year":"2015","journal-title":"Int J Radiat Res"},{"key":"10.1016\/j.radonc.2020.07.030_b0240","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/oxfordjournals.jjco.a023218","article-title":"Impact of tumor extent and location on treatment outcome in patients with stage III non-small cell lung cancer treated with radiation therapy","volume":"26","author":"Hayakawa","year":"1996","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0245","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.21037\/jtd.2017.10.47","article-title":"Optimal managements of stage IIIA (N2) non-small cell lung cancer patients: a population-based survival analysis","volume":"9","author":"Pang","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.radonc.2020.07.030_b0250","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.athoracsur.2015.07.022","article-title":"Pneumonectomy for clinical stage IIIA non-small cell lung cancer: The impact of neoadjuvant therapy","volume":"101","author":"Broderick","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.radonc.2020.07.030_b0255","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ijrobp.2018.04.053","article-title":"Incidence and impact of pretreatment tumor cavitation on survival outcomes of stage III squamous cell lung cancer patients treated with radical concurrent chemoradiation therapy","volume":"101","author":"Topkan","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.07.030_b0260","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jjco\/hyt164","article-title":"Surgical outcomes after initial surgery for clinical single-station N2 non-small-cell lung cancer","volume":"44","author":"Hishida","year":"2014","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0265","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/cas.12028","article-title":"Long-term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non-small-cell lung cancer","volume":"104","author":"Horinouchi","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.radonc.2020.07.030_b0270","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10147-016-0982-0","article-title":"Impact of early tumor reduction on outcome differs by histological subtype in stage III non-small-cell lung cancer treated with definitive radiotherapy","volume":"21","author":"Kanzaki","year":"2016","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0275","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/jjco\/hyz016","article-title":"Chemoradiotherapy for locally advanced lung cancer patients with interstitial lung abnormalities","volume":"49","author":"Higo","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0280","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cllc.2018.08.018","article-title":"Significance of 18 F-FDG PET parameters according to histologic subtype in the treatment outcome of stage III non-small-cell lung cancer undergoing definitive concurrent chemoradiotherapy","volume":"20","author":"Kim","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.radonc.2020.07.030_b0285","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.21037\/jtd.2018.10.115","article-title":"Upfront surgery in patients with clinical skip N2 lung cancer based on results of modern radiological examinations","volume":"10","author":"Maniwa","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.radonc.2020.07.030_b0290","doi-asserted-by":"crossref","first-page":"527","DOI":"10.5114\/jcb.2017.72605","article-title":"Implantation of computed tomography-guided Iodine-125 seeds in combination with chemotherapy for the treatment of stage III non-small cell lung cancer","volume":"9","author":"Huo","year":"2017","journal-title":"J Contemp Brachyther"},{"key":"10.1016\/j.radonc.2020.07.030_b0295","article-title":"Prognostic value of primary tumor SUVmax on pre-treatment 18F-FDG PET\/CT imaging in patients with stage III non-small cell lung cancer","author":"Y\u0131lmaz","year":"2018","journal-title":"Rev Espa\u00f1ola Med Nucl e Imagen Mol (English Ed"},{"key":"10.1016\/j.radonc.2020.07.030_b0300","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0360-3016(02)02939-5","article-title":"Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies","volume":"54","author":"Firat","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.07.030_b0305","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00259-013-2530-8","article-title":"Volume-based assessment by 18F-FDG PET\/CT predicts survival in patients with stage III non-small-cell lung cancer","volume":"41","author":"Hyun","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2020.07.030_b0310","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.21037\/jtd.2019.03.42","article-title":"Outcomes comparison between neoadjuvant chemotherapy and adjuvant chemotherapy in stage IIIA non-small cell lung cancer patients","volume":"11","author":"Tao","year":"2019","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.radonc.2020.07.030_b0315","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cllc.2018.10.005","article-title":"Pneumonectomy in stage IIIA-N2 NSCLC: should it be considered after neoadjuvant chemotherapy?","volume":"20","author":"Casiraghi","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.radonc.2020.07.030_b0320","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.radonc.2017.08.007","article-title":"Mid-radiotherapy PET\/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer","volume":"125","author":"Gensheimer","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0325","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1148\/radiol.2015142920","article-title":"Stage III non-small cell lung cancer: prognostic value of FDG PET quantitative imaging features combined with clinical prognostic factors","volume":"278","author":"Fried","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2020.07.030_b0330","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.ijrobp.2009.12.060","article-title":"Tumor volume is a prognostic factor in non-small-cell lung cancer treated with chemoradiotherapy","volume":"79","author":"Alexander","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.07.030_b0335","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0360-3016(95)02010-1","article-title":"The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy","volume":"33","author":"Sibley","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.07.030_b0340","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1378\/chest.08-2968","article-title":"Revisiting stage IIIB and IV non-small cell lung cancer: Analysis of the surveillance, epidemiology, and end results data","volume":"136","author":"William","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.radonc.2020.07.030_b0345","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/JTO.0b013e318267d032","article-title":"Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: A surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003","volume":"7","author":"Morgensztern","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0350","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ijrobp.2016.03.018","article-title":"Robust intratumor partitioning to identify high-risk subregions in lung cancer: A pilot study","volume":"95","author":"Wu","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.07.030_b0355","doi-asserted-by":"crossref","first-page":"732","DOI":"10.21037\/tcr.2017.06.52","article-title":"Metabolic volume parameters based on different thresholds with baseline 18F-FDG PET\/CT as prognostic factors for survival in stage III non-small cell lung cancer","volume":"6","author":"Jie","year":"2017","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.radonc.2020.07.030_b0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0157836","article-title":"Early change in metabolic tumor heterogeneity during chemoradiotherapy and its prognostic value for patients with locally advanced non-small cell lung cancer","volume":"11","author":"Dong","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.radonc.2020.07.030_b0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174268","article-title":"Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLC","volume":"12","author":"Agrawal","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.radonc.2020.07.030_b0370","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0360-3016(02)02814-6","article-title":"Influence of tumor volume on survival in patients irradiated for non-small-cell lung cancer","volume":"53","author":"Etiz","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.07.030_b0375","first-page":"165","article-title":"Is there a survival difference between single station and multi-station N2 disease in operated non-small cell lung cancer patients?","volume":"4","author":"Akcam","year":"2015","journal-title":"Cancer Treat Commun"},{"key":"10.1016\/j.radonc.2020.07.030_b0380","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ijrobp.2017.10.003","article-title":"Radiation dose, local disease progression, and overall survival in patients with inoperable non-small cell lung cancer after concurrent chemoradiation therapy","volume":"100","author":"Zhou","year":"2018","journal-title":"Radiat Oncol Biol"},{"key":"10.1016\/j.radonc.2020.07.030_b0385","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ijrobp.2015.11.030","article-title":"Factors associated with early mortality in patients treated with concurrent chemoradiation therapy for locally advanced non-small cell lung cancer","volume":"94","author":"Warner","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.07.030_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2017.11.098","article-title":"A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery","volume":"155","author":"Mao","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.radonc.2020.07.030_b0395","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/cncr.23693","article-title":"ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy","volume":"113","author":"Hwang","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2020.07.030_b0400","first-page":"355","article-title":"Prognostic significance of standardized uptake value of lymph nodes on survival for stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy","volume":"39","author":"Lee","year":"2016","journal-title":"Am J Clin Oncol Cancer Clin Trials"},{"key":"10.1016\/j.radonc.2020.07.030_b0405","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijrobp.2018.07.188","article-title":"Concurrent daily cisplatin and high-dose radiation therapy in patients with stage III non-small cell lung cancer","volume":"102","author":"Dieleman","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.07.030_b0410","first-page":"234","article-title":"Concurrent chemo-radiotherapy for unresectable non-small cell lung cancer invading adjacent great vessels on radiologic findings: is it safe ?","volume":"60","author":"Yoo","year":"2019","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0415","first-page":"659","article-title":"Usefulness of percutaneous microwave ablation for large non-small cell lung cancer: A preliminary report","volume":"18","author":"Pusceddu","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.radonc.2020.07.030_b0420","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1007\/s00259-019-04421-5","article-title":"Introducing FDG PET\/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial","volume":"46","author":"Konert","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2020.07.030_b0425","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3857\/roj.2019.00087","article-title":"Chemoradiotherapy versus radiotherapy alone following induction chemotherapy for elderly patients with stage III lung cancer","volume":"37","author":"Kim","year":"2019","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.radonc.2020.07.030_b0430","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/thx.28.3.354","article-title":"Primary pulmonary cavitating carcinomas","volume":"28","author":"Chaudhuri","year":"1973","journal-title":"Thorax"},{"key":"10.1016\/j.radonc.2020.07.030_b0435","unstructured":"National Comprehensive Cancer Network. NCCN clinical practive guidelines in oncology non-small cell lung cancer. Version 3. 2018."},{"key":"10.1016\/j.radonc.2020.07.030_b0440","first-page":"161","article-title":"Staging of lung cancer","volume":"54","author":"Mountain","year":"1981","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.radonc.2020.07.030_b0445","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC lung cancer staging poject: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0450","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2020191145","article-title":"The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2020.07.030_b0455","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.radonc.2018.10.027","article-title":"Vulnerabilities of radiomic signature development: the need for safeguards","volume":"130","author":"Welch","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2020.07.030_b0460","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1016\/S0169-5002(01)00359-2","article-title":"Neoadjuvant strategies for non-small cell lung cancer","volume":"34","author":"Van Zandwijk","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2020.07.030_b0465","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/srao.2000.9128","article-title":"Neoadjuvant therapy and surgical resection for locally advanced non-small cell lung cancer","volume":"10","author":"Meko","year":"2000","journal-title":"Semin Radiat Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814020306745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814020306745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:12:40Z","timestamp":1759122760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814020306745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":93,"alternative-id":["S0167814020306745"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2020.07.030","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors for overall survival of stage III non-small cell lung cancer patients on computed tomography: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2020.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}